JESSE HAYS: Open Payments
NPI 1851946545 · RUSSELLVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$445 in 25 payments from 12 companies in 2025. Trend: 2023 $365 · 2024 $443 · 2025 $445
Food & beverage: $445
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $77 |
| Novo Nordisk Inc | 3 | $62 |
| Corcept Therapeutics | 3 | $54 |
| GlaxoSmithKline, LLC. | 3 | $47 |
| Esperion Therapeutics, Inc. | 2 | $38 |
| Globus Medical, Inc. | 1 | $31 |
| Dexcom, Inc. | 1 | $29 |
| Amgen Inc. | 2 | $29 |
| Phathom Pharmaceuticals, Inc. | 2 | $28 |
| PFIZER INC. | 1 | $18 |
Products named: Kerendia, Korlym, TRELEGY ELLIPTA, Rybelsus, NEXLETOL, Senza, Dexcom G6 Transmitter, EVENITY.
Industry payments across KY — which companies pay providers there.
